THE DEVELOPMENT OF PROGESTIN THERAPY OF ATYPICAL HYPERPLASIA AND ENDOMETRIAL CANCER

被引：0
|
作者：
VOLKOVA, AT [1 ]
机构：
[1] NN PETROV ONCOL RES INST,LENINGRAD 188646,USSR
来源：
VOPROSY ONKOLOGII | 1987年 / 33卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：109 / 109
页数：1
相关论文
共 50 条
  • [1] Reproductive outcomes after progestin therapy in infertile women with endometrial atypical hyperplasia
    Akman, Levent
    Akdogan, Aysin
    Sahin, Gulnaz
    Terek, Mustafa Cosan
    Ozsaran, Aydin
    Dikmen, Yilmaz
    Goker, Ege Nazan Tavmergen
    Tavmergen, Erol
    [J]. EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2013, 171 (02) : 390 - 391
  • [2] Reproductive outcomes after progestin therapy in infertile women with endometrial atypical hyperplasia
    Akman, L.
    Akdogan, A.
    Sahin, G.
    Terek, C.
    Ozsaran, A.
    Dikmen, Y.
    Goker, E. N. T.
    Tavmergen, E.
    [J]. HUMAN REPRODUCTION, 2012, 27
  • [3] Reproductive and oncologic outcomes after progestin therapy for endometrial complex atypical hyperplasia or carcinoma
    Kudesia, Rashmi
    Singer, Tomer
    Caputo, Thomas A.
    Holcomb, Kevin Michael
    Kligman, Isaac
    Rosenwaks, Zev
    Gupta, Divya
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2014, 210 (03)
  • [4] Reporting Responses to Progestin Therapy in Atypical Endometrial Hyperplasia or Well Differentiated Endometrioid Carcinoma
    Lin, Wanrun
    Wang, Yan
    Zhao, Ruijiao
    Wang, Yiying
    Wang, Yue
    Liu, Yuxin
    Zheng, Wenxin
    [J]. LABORATORY INVESTIGATION, 2022, 102 (SUPPL 1) : 789 - 790
  • [5] Identifying biomarkers of response to progestin therapy in conservatively managed endometrial cancer and atypical hyperplasia/endometrioid intraepithelial neoplasia
    Acosta-Torres, Stefany
    Murdock, Tricia
    Beavis, Anna
    Gough, Ethan
    Fader, Amanda Nickles
    Shih, Ie-Ming
    [J]. GYNECOLOGIC ONCOLOGY, 2022, 166 : S142 - S142
  • [6] Reporting Responses to Progestin Therapy in Atypical Endometrial Hyperplasia or Well Differentiated Endometrioid Carcinoma
    Lin, Wanrun
    Wang, Yan
    Zhao, Ruijiao
    Wang, Yiying
    Wang, Yue
    Liu, Yuxin
    Zheng, Wenxin
    [J]. MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 789 - 790
  • [7] Development of metastatic endometrial. endometriold adenocarcinoma while on progestin therapy for endometrial hyperplasia
    Rubatt, JM
    Slomovitz, BM
    Burke, TW
    Broaddus, RR
    [J]. GYNECOLOGIC ONCOLOGY, 2005, 99 (02) : 472 - 476
  • [8] Treatment efficiency of comprehensive hysteroscopic evaluation and lesion resection combined with progestin therapy in young women with endometrial atypical hyperplasia and endometrial cancer
    Yang, Bingyi
    Xu, Yuhui
    Zhu, Qin
    Xie, Liying
    Shan, Weiwei
    Ning, Chengcheng
    Xie, Bingying
    Shi, Yue
    Luo, Xuezhen
    Zhang, Hongwei
    Chen, Xiaojun
    [J]. GYNECOLOGIC ONCOLOGY, 2019, 153 (01) : 55 - 62
  • [9] Efficacy of combinedmetformin and progestin therapy for complex atypical hyperplasia and well-differentiated endometrial cancer in patients desiring fertility
    Acosta-Torres, S.
    Doglioli, M.
    Varghese, A.
    Tanner, E. J., III
    Stone, R. L.
    Levinson, K. L.
    Beavis, A. L.
    Fader, A. N.
    [J]. GYNECOLOGIC ONCOLOGY, 2019, 154 : 267 - 267
  • [10] Clinical and pathological responses of progestin therapy for non-atypical endometrial hyperplasia: A prospective study
    Rattanachaiyanont, M
    Angsuwathana, S
    Techatrisak, K
    Tanmahasamut, P
    Indhavivadhana, S
    Leerasiri, P
    [J]. JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2005, 31 (02) : 98 - 106
12345